New insights into treating Parkinson’s from yeast, stem cell experiments October 25, 2013 aczechowski_rrnz834o Uncategorized A team of scientists at the Cambridge-based Whitehead Institute for Biomedical Research have identified a compound that can reverse some of the toxicity that occurs in brain cells created from Parkinson’s disease patients’ stem cells. Read More Related Posts Congratulations to Erinc on his promotion to Assistant Professor! Erinc Hallacli becomes Vik's first trainee to be appointed Assistant Professor at Harvard Medical School.… New publication in Nature Communications: 10 pesticides associated with PD are directly toxic to dopaminergic neurons. Congratulations to Rich Krolewski and Edinson Lucumi Moreno in our group, and our collaborators Kim… DOD awards second major grant to BWH-UCLA collaboration! A major grant entitled "Microbiome Impact on Neuro-Immmune and Neurodegenerative Processes in Parkinson’s Disease Patients" has…
Congratulations to Erinc on his promotion to Assistant Professor! Erinc Hallacli becomes Vik's first trainee to be appointed Assistant Professor at Harvard Medical School.…
New publication in Nature Communications: 10 pesticides associated with PD are directly toxic to dopaminergic neurons. Congratulations to Rich Krolewski and Edinson Lucumi Moreno in our group, and our collaborators Kim…
DOD awards second major grant to BWH-UCLA collaboration! A major grant entitled "Microbiome Impact on Neuro-Immmune and Neurodegenerative Processes in Parkinson’s Disease Patients" has…
